secwatch.observer — SEC 8-K summary
======================================

Issuer:     Limitless X Holdings Inc. (LIMX)
CIK:        0001803977
Form:       8-K
Filed at:   2025-05-22T23:59:59+00:00
Accession:  0001641172-25-011965
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Limitless X amends license with CEO-owned LPI, adds three products retroactively
--------------------------------------------------------------------------------

- Amendment adds NZT-48 Lions Mane, NZT-48 For Her, and OneShot Nootropic Pre-Workout to license agreement effective Sept 1, 2023.
- Future products with "NZT" or "OneShot" by LPI automatically covered under existing license terms.
- Clarifies Nov 2023 termination agreements do not apply to NZT-48 or the newly added products.
- LPI is wholly owned by CEO Jaspreet Mathur; all other license terms unchanged.
- Agreement is a related-party transaction; no financial terms disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1803977/000164117225011965/0001641172-25-011965-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1803977/000164117225011965/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-011965

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer